133 related articles for article (PubMed ID: 12901907)
1. Design and synthesis of potent vitamin D receptor antagonists with A-ring modifications: remarkable effects of 2alpha-methyl introduction on antagonistic activity.
Fujishima T; Kojima Y; Azumaya I; Kittaka A; Takayama H
Bioorg Med Chem; 2003 Aug; 11(17):3621-31. PubMed ID: 12901907
[TBL] [Abstract][Full Text] [Related]
2. Highly potent cell differentiation-inducing analogues of 1alpha,25-dihydroxyvitamin D3: synthesis and biological activity of 2-methyl-1,25-dihydroxyvitamin D3 with side-chain modifications.
Fujishima T; Zhaopeng L; Konno K; Nakagawa K; Okano T; Yamaguchi K; Takayama H
Bioorg Med Chem; 2001 Feb; 9(2):525-35. PubMed ID: 11249144
[TBL] [Abstract][Full Text] [Related]
3. Efficient synthesis and biological evaluation of all A-ring diastereomers of 1alpha,25-dihydroxyvitamin D3 and its 20-epimer.
Fujishima T; Konno K; Nakagawa K; Kurobe M; Okano T; Takayama H
Bioorg Med Chem; 2000 Jan; 8(1):123-34. PubMed ID: 10968271
[TBL] [Abstract][Full Text] [Related]
4. Further synthetic and biological studies on vitamin D hormone antagonists based on C24-alkylation and C2alpha-functionalization of 25-dehydro-1alpha-hydroxyvitamin D(3)-26,23-lactones.
Saito N; Matsunaga T; Saito H; Anzai M; Takenouchi K; Miura D; Namekawa J; Ishizuka S; Kittaka A
J Med Chem; 2006 Nov; 49(24):7063-75. PubMed ID: 17125259
[TBL] [Abstract][Full Text] [Related]
5. Novel ring A stereoisomers of 2-methyl-1alpha,25-dihydroxyvitamin D(3) and 2-methyl-20-epi-1alpha,25-dihydroxyvitamin D(3): transactivation of target genes and modulation of differentiation in human promyelocytic leukemia (HL-60) cells.
Nakagawa K; Kurobe M; Ozono K; Konno K; Fujishima T; Takayama H; Okano T
Biochem Pharmacol; 2000 Mar; 59(6):691-702. PubMed ID: 10677586
[TBL] [Abstract][Full Text] [Related]
6. 2,2-Functionalized analogues of 1alpha,25-dihydroxyvitamin D3, the potent inducers of cell differentiation.
Fujishima T; Kittaka A; Kurihara M; Saito N; Honzawa S; Kishimoto S; Sugiura T; Waku K; Takayama H
J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):89-92. PubMed ID: 15225752
[TBL] [Abstract][Full Text] [Related]
7. Systematic studies on synthesis, structural elucidation, and biological evaluation of A-ring diastereomers of 2-methyl-1alpha,25-dihydroxyvitamin D(3) and 20-epi-2-methyl-1alpha,25-dihydroxyvitamin D(3).
Takayama H; Konno K; Fujishima T; Maki S; Liu Z; Miura D; Chokki M; Ishizuka S; Smith C; DeLuca HF; Nakagawa K; Kurobe M; Okano T
Steroids; 2001; 66(3-5):277-85. PubMed ID: 11179735
[TBL] [Abstract][Full Text] [Related]
8. Highly potent vitamin D receptor antagonists: design, synthesis, and biological evaluation.
Saito N; Kittaka A
Chembiochem; 2006 Oct; 7(10):1479-90. PubMed ID: 16871612
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, biological evaluation, and conformational analysis of A-ring diastereomers of 2-methyl-1,25-dihydroxyvitamin D(3) and their 20-epimers: unique activity profiles depending on the stereochemistry of the A-ring and at C-20.
Konno K; Fujishima T; Maki S; Liu Z; Miura D; Chokki M; Ishizuka S; Yamaguchi K; Kan Y; Kurihara M; Miyata N; Smith C; DeLuca HF; Takayama H
J Med Chem; 2000 Nov; 43(22):4247-65. PubMed ID: 11063621
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and testing of 2alpha-modified 1alpha,25-dihydroxyvitamin D(3) analogues with a double side chain: marked cell differentiation activity.
Suhara Y; Kittaka A; Kishimoto S; Calverley MJ; Fujishima T; Saito N; Sugiura T; Waku K; Takayama H
Bioorg Med Chem Lett; 2002 Nov; 12(22):3255-8. PubMed ID: 12392726
[TBL] [Abstract][Full Text] [Related]
11. Efficient synthesis of 2-modified 1alpha,25-dihydroxy-19-norvitamin D3 with Julia olefination: high potency in induction of differentiation on HL-60 cells.
Ono K; Yoshida A; Saito N; Fujishima T; Honzawa S; Suhara Y; Kishimoto S; Sugiura T; Waku K; Takayama H; Kittaka A
J Org Chem; 2003 Sep; 68(19):7407-15. PubMed ID: 12968893
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, and biological studies of the A-ring-modified 1,25-dihydroxyvitamin D3 analogs.
Takayama H; Kittaka A; Fujishima T; Suhara Y
Recent Results Cancer Res; 2003; 164():289-317. PubMed ID: 12899530
[TBL] [Abstract][Full Text] [Related]
13. A concise and efficient route to 2alpha-(omega-hydroxyalkoxy)-1alpha,25-dihydroxyvi tam in D3: remarkably high affinity to vitamin D receptor.
Kittaka A; Suhara Y; Takayanagi H; Fujishima T; Kurihara M; Takayama H
Org Lett; 2000 Aug; 2(17):2619-22. PubMed ID: 10990411
[TBL] [Abstract][Full Text] [Related]
14. Novel 2-alkyl-1alpha,25-dihydroxy-19-norvitamin D3: efficient synthesis with Julia olefination, evaluation of biological activity and development of new analyzing system for co-activator recruitment.
Arai MA; Kittaka A
Anticancer Res; 2006; 26(4A):2621-31. PubMed ID: 16886672
[TBL] [Abstract][Full Text] [Related]
15. [Structural refinement of seco-steroidal skeleton and the biological activity through nuclear receptors].
Kittaka A
Yakugaku Zasshi; 2008 Sep; 128(9):1235-50. PubMed ID: 18758137
[TBL] [Abstract][Full Text] [Related]
16. Recent results on A-ring modification of 1alpha,25-dihydroxyvitamin D3: design and synthesis of VDR-agonists and antagonists with high biological activity.
Saito N; Honzawa S; Kittaka A
Curr Top Med Chem; 2006; 6(12):1273-88. PubMed ID: 16848741
[TBL] [Abstract][Full Text] [Related]
17. Concise synthesis and biological activities of 2alpha-alkyl- and 2alpha-(omega-hydroxyalkyl)-20-epi-1alpha,25-dihydroxyvitamin D3.
Honzawa S; Suhara Y; Nihei K; Saito N; Kishimoto S; Fujishima T; Kurihara M; Sugiura T; Waku K; Takayama H; Kittaka A
Bioorg Med Chem Lett; 2003 Oct; 13(20):3503-6. PubMed ID: 14505658
[TBL] [Abstract][Full Text] [Related]
18. Biological activity of CD-ring modified 1alpha,25-dihydroxyvitamin D analogues: C-ring and five-membered D-ring analogues.
Verstuyf A; Verlinden L; van Etten E; Shi L; Wu Y; D'Halleweyn C; Van Haver D; Zhu GD; Chen YJ; Zhou X; Haussler MR; De Clercq P; Vandewalle M; Van Baelen H; Mathieu C; Bouillon R
J Bone Miner Res; 2000 Feb; 15(2):237-52. PubMed ID: 10703925
[TBL] [Abstract][Full Text] [Related]
19. Dramatic enhancement of antagonistic activity on vitamin D receptor: a double functionalization of 1alpha-hydroxyvitamin D3 26,23-lactones.
Saito N; Saito H; Anzai M; Yoshida A; Fujishima T; Takenouchi K; Miura D; Ishizuka S; Takayama H; Kittaka A
Org Lett; 2003 Dec; 5(25):4859-62. PubMed ID: 14653692
[TBL] [Abstract][Full Text] [Related]
20. Structure activity relationship of carboxylic ester antagonists of the vitamin D(3) receptor.
Bury Y; Steinmeyer A; Carlberg C
Mol Pharmacol; 2000 Nov; 58(5):1067-74. PubMed ID: 11040055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
